Electroconvulsive therapy (ECT) is an intervention for patients with a variety of psychiatric conditions. Occasionally, people exhibit dangerous degrees of agitation after this treatment, and some do not respond well to conventional pharmacotherapies. Dexmedetomidine is a central α-2 agonist that can induce significantly calmative effects in persons with post-ECT agitation. The indication for it is in calming individuals with acute and/or recurrent posttreatment agitation. Dexmedetomidine is safe and effective when infused just before, or postictally, at ECT sessions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/YCT.0000000000000393 | DOI Listing |
Publication Analysis
Top Keywords
post-ect agitation
8
benefits dexmedetomidine
4
dexmedetomidine management
4
management post-ect
4
agitation
4
agitation electroconvulsive
4
electroconvulsive therapy
4
therapy ect
4
ect intervention
4
intervention patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!